thiazoles has been researched along with gadolinium chloride in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Huang, J; Wang, K; Wang, P; Zhang, TL; Zou, XM | 1 |
Fet, N; Hata, K; Klinge, U; Minor, T; Nakajima, A; Okamura, Y; Taura, K; Tolba, RH; Uchinami, H; Yamamoto, Y; Yamaoka, Y; Yonezawa, K | 1 |
2 other study(ies) available for thiazoles and gadolinium chloride
Article | Year |
---|---|
Gadolinium inhibits prostate cancer PC3 cell migration and suppresses osteoclast differentiation in vitro.
Topics: Animals; Apoptosis; Blotting, Western; Calcium; Cell Adhesion; Cell Differentiation; Cell Line, Tumor; Cell Movement; Cell Survival; Gadolinium; Humans; Male; MAP Kinase Signaling System; Mice; Mice, Inbred ICR; Microscopy, Confocal; Osteoclasts; Phosphorylation; Prostatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; Tetrazolium Salts; Thiazoles; Wound Healing | 2011 |
Role of preferential cyclooxygenase-2 inhibition by meloxicam in ischemia/reperfusion injury of the rat liver.
Topics: Animals; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Drug Evaluation, Preclinical; Gadolinium; In Situ Nick-End Labeling; Kidney Function Tests; Kupffer Cells; Liver; Liver Diseases; Male; Meloxicam; Rats, Wistar; Reperfusion Injury; Thiazines; Thiazoles; Thromboxane B2; Tumor Necrosis Factor-alpha | 2014 |